Lifecore Biomedical Inc
LFCR
Get informed when a big investor buys or sells
+ FollowMarket Cap$188.3M
Close$
$-6.70
218.2% downside
Current Fair Value
218.2% downsideOvervalued by 218.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $188.30 Million |
|---|---|
| Enterprise Value | $323.51 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.27 |
| Beta | 1.08 |
| Outstanding Shares | 37,477,386 |
Return
| Return on Equity | -164.06% |
|---|---|
| Return on Assets | -15.12% |
| Return on Invested Capital | -1.61% |
Valuation & Multiples
| P/E Ratio | -5.52 |
|---|---|
| PEG | -386.31 |
| Price to Sales | 1.89 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.56 |
| Enterprise Value to EBIT | -97.8 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.48 |
| Debt to Equity | 7.51 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 6, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$25.96 M
Average shareholder expectationNext Earnings Call
Expected Date
July 31, 2026
EPS Estimate
$-0.24
Average shareholder expectationRevenue Estimate
$30.08 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7799▲ 66.52% |
|---|---|
| Total Calls | 42,700▼ 55.47% |
| Total Puts | 33,300▲ 202.73% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 67.03%▲ 0.74% |
|---|---|
| Total Invested | $112.29M▼ 50.27% |
| Investors Holding | 108▲ 1.00% |
ESG Score
No data
About Lifecore Biomedical Inc
796 employees
CEO: Albert Bolles Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the foo...